台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

4. Immunotherapy novel combination and potential breakthrough therapy in HNSCC_Dr. Mei-Kim Ang (2024.11.03)

2024-12-18 • 觀看: 1 • 回應: 0 • embed
3. What can we expect in the future development of oncology pipelines beyondADC?_陳偉武 (2024.11.03)

2024-12-18 • 觀看: 1 • 回應: 0 • embed
2. How physicians collaboratewith industry for drug development?_吳尚儒 (2024.11.03)

2024-12-18 • 觀看: 1 • 回應: 0 • embed
1. Tsunami in oncology: development in ADC_Dr.Andrea Lauer (2024.11.03)

2024-12-18 • 觀看: 1 • 回應: 0 • embed
2. Role of Immunotherapy inPerioperative Approach of Muscle InvasiveUrothelial Cancer_蔡育傑 (2024.11.02)

2024-12-18 • 觀看: 5 • 回應: 0 • embed
1. A New Era of Front-lineMetastatic Urothelial Cancer_Prof Eiji Kikuchi (2024.11.02)

2024-12-18 • 觀看: 7 • 回應: 0 • embed
【🎬線上】Advanced Prostate Cancer Webinar 2024-11-28 (四) 19:00 ~ 20:30

2024-12-18 • 觀看: 14 • 回應: 0 • embed
(WUF-2) Vesicoureteral reflux—an argument for CHOPserveration_Aseem Shukla

2024-12-14 • 觀看: 8 • 回應: 0 • 連結
活動相簿

2024-12-14 • 觀看: 0 • 回應: 0 • album
(TSO-1) PRP treatment for andrology _姜宜妮

2024-12-14 • 觀看: 18 • 回應: 0 • 連結
活動相簿

2024-12-14 • 觀看: 0 • 回應: 0 • album
(SF5-2) Update on male urinary incontinence_簡佑軒

2024-12-14 • 觀看: 13 • 回應: 0 • 連結

Prev
49
50
51
52
53
54
55
56
57
58
Next
/ 1052